Ipca Laboratories shares gained 7 percent after the company posted healthy earnings for the December 2024 quarter.
The shares of IPCA Laboratories Ltd touched an intraday high of Rs 1,524.85 per share on the NSE, rising 7.4 percent. The scrip gained after four days of consecutive fall.
The company on Thursday said its consolidated net profit grew 38 percent year-on-year to Rs 248 crore in the December quarter. The drug firm had reported a net profit of Rs 180 crore in the year-ago period.
Revenue from operations rose 9.4 percent to Rs 2,245.4 crore for the third quarter of the current fiscal year as compared with Rs 2,053 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
The earnings before interest, taxes, depreciation and amortization (EBITDA) was up 40 percent at Rs 463 crore in the December 2024 quarter from Rs 331 crore year-on-year (YOY), while the margin was reported at 20.6 percent against 16 percent on-year.
Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
